BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20619169)

  • 1. [Psychotropic drugs and the involvement of the Akt/GSK3 signalling pathway in mental illnesses].
    Del'Guidice T; Beaulieu JM
    Med Sci (Paris); 2010; 26(6-7):647-51. PubMed ID: 20619169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Akt/GSK3 signaling in the action of psychotropic drugs.
    Beaulieu JM; Gainetdinov RR; Caron MG
    Annu Rev Pharmacol Toxicol; 2009; 49():327-47. PubMed ID: 18928402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health.
    Beaulieu JM
    J Psychiatry Neurosci; 2012 Jan; 37(1):7-16. PubMed ID: 21711983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotic drug actions on gene modulation and signaling mechanisms.
    Molteni R; Calabrese F; Racagni G; Fumagalli F; Riva MA
    Pharmacol Ther; 2009 Oct; 124(1):74-85. PubMed ID: 19540875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An emerging role for Wnt and GSK3 signaling pathways in schizophrenia.
    Singh KK
    Clin Genet; 2013 Jun; 83(6):511-7. PubMed ID: 23379509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drugs for psychiatric disorders.
    Med Lett Drugs Ther; 1976 Oct; 18(22):89-96. PubMed ID: 10519
    [No Abstract]   [Full Text] [Related]  

  • 8. Psychologists and psychoactive drugs.
    Murray JB
    Genet Psychol Monogr; 1978 Nov; 98(Second Half):281-323. PubMed ID: 31317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereochemical considerations of the actions of some psychotropic drugs.
    Smith DF
    Pharmacopsychiatry; 1985 May; 18(3):225-30. PubMed ID: 2861608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of PI3K/Akt/GSK-3 pathway by cannabinoids in the brain.
    Ozaita A; Puighermanal E; Maldonado R
    J Neurochem; 2007 Aug; 102(4):1105-14. PubMed ID: 17484726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychotropic drug use in older people with mental illness with particular reference to antipsychotics: a systematic study of tolerability and use in different diagnostic groups.
    Curran S; Turner D; Musa S; Wattis J
    Int J Geriatr Psychiatry; 2005 Sep; 20(9):842-7. PubMed ID: 16116576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National trends in psychotropic medication polypharmacy in office-based psychiatry.
    Mojtabai R; Olfson M
    Arch Gen Psychiatry; 2010 Jan; 67(1):26-36. PubMed ID: 20048220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Akt GSK-3 pathway as a target in genistein-induced inhibition of TRAMP prostate cancer progression toward a poorly differentiated phenotype.
    El Touny LH; Banerjee PP
    Carcinogenesis; 2007 Aug; 28(8):1710-7. PubMed ID: 17468512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GSK3 promotes arsenite-induced apoptosis via facilitation of mitochondria disruption.
    Watcharasit P; Thiantanawat A; Satayavivad J
    J Appl Toxicol; 2008 May; 28(4):466-74. PubMed ID: 17849503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychopharmacology in the aged. Use of psychotropic drugs in geriatric patients.
    Davis JM
    J Geriatr Psychiatry; 1974; 7(2):145-59. PubMed ID: 4155416
    [No Abstract]   [Full Text] [Related]  

  • 16. Glycogen synthase kinase 3 substrates in mood disorders and schizophrenia.
    Cole AR
    FEBS J; 2013 Nov; 280(21):5213-27. PubMed ID: 23796137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in the protein kinase B signaling pathway.
    Woodgett JR
    Curr Opin Cell Biol; 2005 Apr; 17(2):150-7. PubMed ID: 15780591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways.
    Rommel C; Bodine SC; Clarke BA; Rossman R; Nunez L; Stitt TN; Yancopoulos GD; Glass DJ
    Nat Cell Biol; 2001 Nov; 3(11):1009-13. PubMed ID: 11715022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of serotonergic agents in the clinical assessment of central serotonin function.
    Murphy DL; Mueller EA; Garrick NA; Aulakh CS
    J Clin Psychiatry; 1986 Apr; 47 Suppl():9-15. PubMed ID: 3514586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PI3K/Akt: getting it right matters.
    Franke TF
    Oncogene; 2008 Oct; 27(50):6473-88. PubMed ID: 18955974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.